Price Alert

West Pharmaceutical Servi... (WST)

NYSE: WST · Real-Time Price · USD

272.50

-0.66 (-0.24%)

At close: Oct 03, 2025, 3:59 PM

272.56

0.02%

Pre-market: Oct 06, 2025, 09:16 AM EDT

West Pharmaceutical Services Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	766.2M	698.2M	748.5M	746.9M	702M	695.3M	732.1M	747.5M	754.2M	715.9M	708.4M	686.4M	771.6M	719.7M	729M	706.6M	724.1M	671M
Cost of Revenue	493M	465.5M	474.1M	481.7M	470.7M	464M	453.1M	458M	462M	445.3M	445M	418.9M	451.8M	434.9M	436.4M	418.1M	407.7M	398.3M
Gross Profit	273.2M	232.7M	274.4M	265.2M	231.3M	231.3M	279M	289.5M	292.2M	270.6M	263.4M	267.5M	319.8M	284.8M	292.6M	288.5M	316.4M	272.7M
Operating Income	158.2M	128.4M	170.6M	167.8M	130.8M	127M	170.6M	191.1M	187.3M	167.5M	161.8M	187.6M	223.9M	186.8M	180.9M	183.5M	209.9M	180.3M
Interest Income	3.6M	4.1M	4.8M	4.6M	4M	6.2M	9.4M	8.8M	5M	4.8M	2.9M	1.5M	400K	300K	300K	400K	200K	100K
Pretax Income	162M	113.9M	166.9M	168.4M	133.2M	131.7M	171.5M	190.7M	189.9M	163.6M	131.9M	141M	232.7M	195M	181.9M	187.6M	219.6M	179.9M
Net Income	131.8M	89.8M	130.1M	136M	111.3M	115.3M	137M	161.3M	155.1M	140M	103M	120.6M	188.5M	173.8M	147.7M	175.6M	187.3M	151.2M
Selling & General & Admin	95.9M	88M	85.3M	81.9M	83M	86.7M	90M	89M	88.4M	86M	85.7M	66.3M	81.5M	83.4M	98M	91.9M	92.7M	80.2M
Research & Development	19.1M	16.3M	18.5M	15.5M	17.5M	17.6M	18.4M	16.4M	16.5M	17.1M	15.9M	13.6M	14.4M	14.6M	13.7M	13.1M	13.8M	12.2M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-7M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	115M	104.3M	103.8M	97.4M	100.5M	104.3M	108.4M	98.4M	104.9M	103.1M	101.6M	79.9M	95.9M	98M	111.7M	105M	106.5M	92.4M
Interest Expense	100K	400K	n/a	700K	1.5M	1.5M	1.1M	2.9M	2.6M	2.2M	1.6M	2.1M	1.8M	2.1M	3.1M	1.7M	1.8M	1.8M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	608M	569.8M	577.9M	579.1M	571.2M	568.3M	561.5M	556.4M	566.9M	548.4M	546.6M	498.8M	547.7M	532.9M	548.1M	523.1M	514.2M	490.7M
Income Tax Expense	30.2M	24.1M	36.8M	32.4M	21.9M	16.4M	34.5M	29.4M	34.8M	23.6M	28.9M	20.4M	44.2M	21.2M	34.2M	12M	32.3M	28.7M
Shares Outstanding (Basic)	72.3M	72.5M	73M	72.8M	73M	73.5M	74.1M	74.3M	74.3M	74.5M	74.4M	74.4M	74.4M	74.4M	74.5M	74.1M	74M	73.9M
Shares Outstanding (Diluted)	72.8M	73M	73.7M	73.4M	73.7M	74.3M	75M	75.3M	75.4M	75.7M	75.6M	75.7M	75.8M	76M	76.4M	76M	75.7M	75.8M
EPS (Basic)	1.82	1.24	1.79	1.87	1.52	1.57	1.85	2.17	2.09	1.88	1.38	1.62	2.53	2.34	1.98	2.37	2.53	2.04
EPS (Diluted)	1.82	1.23	1.78	1.85	1.51	1.55	1.83	2.14	2.06	1.85	1.36	1.59	2.49	2.29	1.93	2.31	2.47	1.99
EBITDA	198.5M	150.9M	205.6M	205.4M	169.1M	164.5M	205.2M	225.6M	221.6M	191.7M	161.4M	168.1M	259.1M	219.1M	219.4M	212.8M	241.6M	205.8M
EBIT	157.1M	110.9M	164.9M	165.2M	130.2M	128.9M	169.3M	189.9M	187.5M	160.1M	130.3M	138.3M	229M	189.5M	185M	182.8M	212.8M	176.7M
Depreciation & Amortization	41.4M	40M	40.7M	40.2M	38.9M	35.6M	35.9M	35.7M	34.1M	31.6M	31.1M	29.8M	30.1M	29.6M	34.4M	30M	28.8M	29.1M